Clinical Trials in Houston

Showing 4901-4920 of 17,885 trials

Study of Olverembatinib (HQP1351) in Patients With CP-CML

NCT06423911

A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2)

Chronic Myeloid LeukemiaCMLCML, Chronic Phase

Ascentage Pharma Group Inc.285 participantsStarted Feb 2024

Houston, Texas, United States

COMPLETEDPhase 3< 1 mile

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

NCT05275400

The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin. The study consists of a 3-week screening/lead-in period, a 78-week treatment period and a 5-week safety follow-up period. The study will last up to 86 weeks.

Type 2 Diabetes

Eli Lilly and Company986 participantsStarted Mar 2022

Little Rock, Arkansas, United States • Concord, California, United States • Escondido, California, United States +124 more locations

Study of Olverembatinib (HQP1351) in Patients With CP-CML

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Find Trials by Condition in Houston

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata

Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

MAGIC Ruxolitinib for aGVHD

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis

Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)

Prospective Multi-Center Study of Short-Term Outcomes After Complex Cholecystectomy

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

Global Utilization And Registry Database for Improved heArt preservatioN

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA

Long Term Extension Trial of Setmelanotide